These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23938599)

  • 21. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
    Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
    Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
    Uchino K; Massaro L; Jovin TG; Hammer MD; Wechsler LR
    J Stroke Cerebrovasc Dis; 2010; 19(6):417-23. PubMed ID: 21051004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months.
    Meretoja A; Weir L; Ugalde M; Yassi N; Yan B; Hand P; Truesdale M; Davis SM; Campbell BC
    Neurology; 2013 Sep; 81(12):1071-6. PubMed ID: 23946303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
    Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
    Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medicine. Stroke--tPA and the clinic.
    Marler JR; Goldstein LB
    Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a stroke alert protocol in the emergency department: a pilot study.
    Hoegerl C; Goldstein FJ; Sartorius J
    J Am Osteopath Assoc; 2011 Jan; 111(1):21-7. PubMed ID: 21258013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advance hospital notification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator.
    Abdullah AR; Smith EE; Biddinger PD; Kalenderian D; Schwamm LH
    Prehosp Emerg Care; 2008; 12(4):426-31. PubMed ID: 18924004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing.
    Wang Y; Wu D; Zhao X; Ma R; Guo X; Wang C; Liu L; Zhao W; Wang Y
    Surg Neurol; 2009 Aug; 72 Suppl 1():S2-7. PubMed ID: 18423545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?
    Gilligan AK; Thrift AG; Sturm JW; Dewey HM; Macdonell RA; Donnan GA
    Cerebrovasc Dis; 2005; 20(4):239-44. PubMed ID: 16123543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus.
    Levi CR; ; ;
    Med J Aust; 2004 Jun; 180(12):634-6. PubMed ID: 15200362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments.
    Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC
    J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis?
    Tai YJ; Weir L; Hand P; Davis S; Yan B
    Intern Med J; 2012 Dec; 42(12):1316-24. PubMed ID: 22212180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous tissue plasminogen activator for stroke: a review of the ECASS III results in relation to prior clinical trials.
    Cronin CA
    J Emerg Med; 2010 Jan; 38(1):99-105. PubMed ID: 19765940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
    Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
    J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technology and collaboration Drive Dramatic Improvements in Stroke Treatment.
    Smith SJ
    EMS World; 2016 Aug; 45(8):20-25. PubMed ID: 29846047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.